IL2 and type 1 diabetes mellitus: In a previous work (7), we demonstrated that, following TCR engagement, LiposiRNA treatment restored in PBMC of heterozygous T1D patients IL-2 production which is known to be paradoxically reduced than in wild type T1D patients.